Alimera Sciences Inc (ALIM)
5.54
0.00 (0.00%)
USD |
NASDAQ |
Sep 18, 16:00
Alimera Sciences Revenue (TTM): 99.68M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 99.68M |
March 31, 2024 | 90.22M |
December 31, 2023 | 80.75M |
September 30, 2023 | 68.48M |
June 30, 2023 | 58.71M |
March 31, 2023 | 55.78M |
December 31, 2022 | 54.13M |
September 30, 2022 | 54.06M |
June 30, 2022 | 52.61M |
March 31, 2022 | 59.71M |
December 31, 2021 | 59.03M |
September 30, 2021 | 58.84M |
June 30, 2021 | 59.16M |
March 31, 2021 | 47.50M |
December 31, 2020 | 50.82M |
September 30, 2020 | 54.39M |
June 30, 2020 | 54.77M |
March 31, 2020 | 55.59M |
December 31, 2019 | 53.94M |
September 30, 2019 | 51.71M |
June 30, 2019 | 50.00M |
Date | Value |
---|---|
March 31, 2019 | 49.86M |
December 31, 2018 | 46.60M |
September 30, 2018 | 40.63M |
June 30, 2018 | 39.27M |
March 31, 2018 | 38.92M |
December 31, 2017 | 35.91M |
September 30, 2017 | 37.45M |
June 30, 2017 | 35.96M |
March 31, 2017 | 35.15M |
December 31, 2016 | 34.33M |
September 30, 2016 | 29.48M |
June 30, 2016 | 28.08M |
March 31, 2016 | 24.30M |
December 31, 2015 | 22.44M |
September 30, 2015 | 18.36M |
June 30, 2015 | 13.86M |
March 31, 2015 | 10.28M |
December 31, 2014 | 8.423M |
September 30, 2014 | 7.617M |
June 30, 2014 | 5.967M |
March 31, 2014 | 3.956M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
47.50M
Minimum
Mar 2021
99.68M
Maximum
Jun 2024
61.48M
Average
55.78M
Median
Mar 2023
Revenue (TTM) Benchmarks
ANI Pharmaceuticals Inc | 555.46M |
Altimmune Inc | 0.409M |
Avid Bioservices Inc | 142.36M |
Silk Road Medical Inc | 191.43M |
NovaBay Pharmaceuticals Inc | 12.02M |